RAML effectiveness
Tumors
TUMORS
About one-third of our patients were responders (> 30% reduction of LD) versus 42% in EXIST-2 [Volume measurement was not feasible for various reasons; it was too time-consuming, the automated method used for volume measurement did not capture accurate volume assessment, and some images were only taken in single sections. The change in size of rAML was measured according to Response Evaluation Criteria in Solid Tumors (RECIST) [